Literature DB >> 6797752

Exacerbation of vasotonic angina pectoris by propranolol.

R M Robertson, A J Wood, W K Vaughn, D Robertson.   

Abstract

Using a double-blind protocol, we investigated the use of propranolol in patients with coronary artery spasm as assessed by subjective and objective variables. Both low-dose (40 mg every 6 hours) and high-dose (160 mg every 6 hours) propranolol were administered. At both doses, the duration of angina attacks was significantly prolonged but the frequency was not. We conclude that propranolol at doses up to 160 mg every 6 hours as single therapy is frequently detrimental in angina pectoris due to coronary artery spasm and should not be used as the sole treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6797752     DOI: 10.1161/01.cir.65.2.281

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  Coronary Artery Spasm.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

2.  Syncope and recurrent long sinus arrest in vasospastic angina.

Authors:  J Hasegawa; H Kitamura; H Mashiba
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

3.  Action of nifedipine in ischemic heart disease.

Authors:  D D Miller; P Théroux; D D Waters; G B Pelletier
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

4.  Coronary plaque classification using intravascular ultrasound -- radiofrequency analysis in a patient with severe coronary vasospasm.

Authors:  Andreas König; Marius Oepke; Markus Leibig; Volker Klauss
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

5.  Reflex epicardial coronary vasoconstriction elicited by nicotine in anaesthetized dogs.

Authors:  C G Sobey; G J Dusting; O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

6.  Adverse cardiovascular outcomes in women: blame the amygdala?

Authors:  Puja K Mehta; Bruno B Lima; Michael D Nelson; C Noel Bairey Merz
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-06-01       Impact factor: 6.875

Review 7.  Pharmacology of acute effort angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 8.  Antianginal actions of beta-adrenoceptor antagonists.

Authors:  Stephen T O'Rourke
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

Review 9.  Unstable angina: 1985 update.

Authors:  J A Cairns
Journal:  CMAJ       Date:  1986-04-01       Impact factor: 8.262

10.  Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.

Authors:  A A Quyyumi; T Crake; C M Wright; L J Mockus; K M Fox
Journal:  Br Heart J       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.